A meta-analysis of published data from 1999 to 2017 (14), with technical platforms including PCR, Sanger sequencing, and high-throughput sequencing, included a total of 35178 cases of BRCA1/2 testing in the Chinese population, of which the carrier rate of ovarian cancer was 21.8%. This evidence concerns the gene BRCA1 and ovarian carcinoma.